Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi

Veterinary Immunology and Immunopathology

Volumn 138, Issue 3, 2010, Pages 198-205

  Ryan, Clare ^a   Giguère, Steeve ^b   Fultz, Lisa ^a   Long, Maureen T ^c   Crawford, P Cynda ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c Scott)   (United States)

Author keywords

Cytokines; Foals; Neonatal immunity; Rhodococcus equi

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 12P40; MESSENGER RNA; MITOGENIC AGENT; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; LEUKOCYTE FUNCTION; LUNG VOLUME; MACROPHAGE FUNCTION; MONOCYTE; NEUTROPHIL; NONHUMAN; PARAPOXVIRUS; PARAPOXVIRUS OVIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PROPIONIBACTERIUM ACNES; RESPIRATORY BURST; RHODOCOCCUS EQUI;

ACTINOMYCETALES INFECTIONS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; CYTOKINES; HORSE DISEASES; HORSES; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; NEUTROPHILS; PARAPOXVIRUS; PROPIONIBACTERIUM ACNES; RESPIRATORY BURST; RHODOCOCCUS EQUI; RNA, MESSENGER; VACCINES, INACTIVATED;

OVIS; PARAPOXVIRUS; PROPIONIBACTERIUM ACNES; RHODOCOCCUS EQUI;

EID: 78449288924     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.07.027     Document Type: Article

References (43)

1. Ahmed S.A., Gogal R.M., Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods 1994, 170:211-224.
2. Ainsworth D.M., Grunig G., Matychak M.B., Young J., Wagner B., Erb H.N., Antczak D.F. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 2003, 96:83-91.
3. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet. Immunol. Immunopathol. 2003, 92:75-85.
4. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet Immunol. Immunopathol. 2006, 112:199-209.
5. Cormack S., Alkemade S., Rogan D. Clinical study evaluating a purified mycobacterial cell wall extract for the treatment of equine respiratory disease. Equine Pract. 1991, 13:18.
6. Darrah P.A., Hondalus M.K., Chen Q., Ischiropoulos H., Mosser D.M. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 2000, 68:3587-3593.
7. Davis E.G., Rush B.R., Blecha F. Increases in cytokine and antimicrobial peptide gene expression in horses by immunomodulation with Propionibacterium acnes. Vet. Ther. 2003, 4:5-11.
8. Flaminio M.J., Rush B.R., Davis E.G., Hennessy K., Shuman W., Wilkerson M.J. Simultaneous flow cytometric analysis of phagocytosis and oxidative burst activity in equine leukocytes. Vet. Res Commun. 2002, 26:85-92.
9. Flaminio M.J., Rush B.R., Shuman W. Immunologic function in horses after non-specific immunostimulant administration. Vet. Immunol. Immunopathol. 1998, 63:303-315.
10. Fogarty U., Leadon D.P. Comparison of systemic and local respiratory tract cellular immunity in the neonatal foal. J. Reprod. Fertil. Suppl. 1987, 35:593-598.
11. Forster R., Wolf G., Mayr A. Highly attenuated poxviruses induce functional priming of neutrophils in vitro. Arch. Virol. 1994, 136:219-226.
12. Friebe A., Siegling A., Friederichs S., Volk H.D., Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J. Virol. 2004, 78:9400-9411.
13. Garton N.J., Gilleron M., Brando T., Dan H.H., Giguère S., Puzo G., Prescott J.F., Sutcliffe I.C. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J. Biol. Chem. 2002, 277:31722-31733.
14. Giguère S., Gaskin J.M., Miller C., Bowman J.L. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J. Am. Vet. Med. Assoc. 2002, 220:59-63.
15. Giguère S., Prescott J.F. Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi. Infect. Immun. 1998, 66:1848-1854.
16. Hondalus M.K., Mosser D.M. Survival and replication of Rhodococcus equi in macrophages. Infect. Immun. 1994, 62:4167-4175.
17. Horohov D.W., Breathnach C.C., Sturgill T.L., Rashid C., Stiltner J.L., Strong D., Nieman N., Holland R.E. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis. Equine Vet. J. 2008, 40:468-472.
18. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin M.K., Chu K.K., Magdesian K.G., Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 2001, 15:171-175.
19. Hurley J.R., Begg A.P. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust. Vet. J. 1995, 72:418-420.
20. Jacks S., Giguère S., Crawford P.C., Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 2007, 14:669-677.
21. Jacks S., Giguère S., Prescott J.F. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin. Vaccine Immunol. 2007, 14:369-374.
22. Kanaly S.T., Hines S.A., Palmer G.H. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 1996, 64:1126-1132.
23. Kasuga-Aoki H., Takai S., Sasaki Y., Tsubaki S., Madarame H., Nakane A. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 1999, 96:122-127.
24. Liu I.K., Walsh E.M., Bernoco M., Cheung A.T. Bronchoalveolar lavage in the newborn foal. J. Reprod. Fertil. 1987, 35(Suppl.):587-592.
25. Lopez A.M., Hines M.T., Palmer G.H., Alperin D.C., Hines S.A. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab Immunol. 2002, 9:1270-1276.
26. Martens J.G., Martens R.J., Renshaw H.W. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am. J. Vet. Res. 1988, 49:295-299.
27. Martens R.J., Cohen N.D., Jones S.L., Moore T.A., Edwards J.F. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect. Immun. 2005, 73:7040-7042.
28. Martens R.J., Martens J.G., Fiske R.A. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. 1991, 12(Suppl.):19-22.
29. Nerren J.R., Martens R.J., Payne S., Murrell J., Butler J.L., Cohen N.D. Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro. Vet. Immunol. Immunopathol. 2009, 127:212-219.
30. Nestved A. Evaluation of an immunostimulant in preventing shipping related respiratory disease. J. Equine Vet. Sci. 1996, 16:78.
31. Prescott J.F., Patterson M.C., Nicholson V.M., Morein B., Yager J.A. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice. Vet. Microbiol. 1997, 56:213-225.
32. Raabe M.R., Issel C.J., Montelaro R.C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods 1998, 71:87-104.
33. Richardson M.P., Ayliffe M.J., Helbert M., Davies E.G. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J. Immunol. Methods 1998, 219:187-193.
34. Rush B.R., Flaminio M.J. Immunomodulation in horses. Vet. Clin. North Am. Equine Pract. 2000, 16:183-197.
35. Ryan C., Giguère S., Hagen J., Hartnett C., Kalyuzhny A.E. Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay. Vet. Immunol. Immunopathol. 2010, 133:66-71.
36. Schutze N., Raue R., Buttner M., Kohler G., McInnes C.J., Alber G. Specific antibodies induced by inactivated parapoxvirus ovis potently enhance oxidative burst in canine blood polymorphonuclear leukocytes and monocytes. Vet. Microbiol. 2010, 140:81-91.
37. Slovis N.M., McCracken J.L., Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms. Proc. Am. Assoc. Equine Pract. 2005, 51:274-278.
38. Sturgill T.L., Horohov D.W. Interferon-gamma expression in young foals when treated with an immunostimulant or plasma. Proc. Am. Assoc. Equine Pract. 2006, 52:237-241.
39. Trinchieri G., Gerosa F. Immunoregulation by interleukin-12. J. Leukoc. Biol. 1996, 59:505-511.
40. Vail C.D., Nestved A., Martens J.B. Adjunc treatment of equine respiratory disease complex (ERDC) with the Propionibacterium acnes, immunostimulant, EqStim. J. Equine Vet. Sci. 1990, 10:399.
41. Weber O., Siegling A., Friebe A., Limmer A., Schlapp T., Knolle P., Mercer A., Schaller H., Volk H.D. Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J. Gen. Virol. 2003, 84:1843-1852.
42. Witonsky S., Gogal R.M., Buechner-Maxwell V., Ahmed S.A. Immunologic analysis of blood samples obtained from horses and stored for twenty-four hours. Am. J. Vet. Res. 2003, 64:1003-1009.
43. Ziebell K.L., Steinmann H., Kretzdorn D., Schlapp T., Failing K., Schmeer N. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses. Zentralbl. Veterinarmed. [B] 1997, 44:529-536.